ANDA 89026, held by Watson Laboratories. Procainamide Hydrochloride.
As of Nov 21, 2026, ANDA 89026 (Procainamide Hydrochloride), held by Watson Laboratories, was first approved by FDA on Oct 22, 1985, with 11 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 22, 1985 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Procainamide Hydrochloride250MG · tablet, extended release;oral | Procainamide Hydrochloride | Discontinued |
| Jun 8, 1998 | Supplement 11Manufacturing | Approved | None posted |
| May 6, 1993 | Supplement 5Manufacturing | Approved | None posted |
| May 6, 1993 | Supplement 4Manufacturing | Approved | None posted |
| May 6, 1993 | Supplement 3Manufacturing | Approved | None posted |
| Feb 19, 1992 | Supplement 9Manufacturing | Approved | None posted |
| Dec 16, 1991 | Supplement 10Labeling | Approved | None posted |
| Sep 26, 1991 | Supplement 8Labeling | Approved | None posted |
| Aug 7, 1991 | Supplement 6Manufacturing | Approved | None posted |
| Jan 28, 1991 | Supplement 7Manufacturing | Approved | None posted |
| Jan 12, 1989 | Supplement 1Labeling | Approved | None posted |
| Aug 10, 1988 | Supplement 2Labeling | Approved | None posted |
| Oct 22, 1985 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters